As of 4:00pm ET
| +0.09 / +0.92%|
The 1 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a -29.44% decrease from the last price of 9.92.
The current consensus among 2 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.